Saturday 17 October 2026
Export AVR’s income statement to Excel — free account
Anteris Technologies Global Corp.
AVR Healthcare Medical Instruments & Supplies
Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024. In the quarter to June 2026, revenue grew 63.3%, EPS grew 48.3%, free cash flow fell 6.84% and total debt rose 8.15%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.05
0.31
−4.87%
Follow AVR
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Piotroski F-Score |
— | — | 2 |
P/E ratio |
0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | (3.34) | (31.49) |
P/S ratio |
0.00 | 41.81 | 96.28 |
Altman Z″-Score (non-manufacturers) |
(26.95) | (9.32) | (81.60) |
P/FCF ratio |
0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (4.28) | (6.30) |
P/Operating CF |
(8.15) | (6.20) | (9.94) |
P/B ratio |
6.08 | 1.80 | 0.00 |
Price to Tangible BV |
6.08 | 1.81 | 0.00 |
EV/Sales |
0.00 | 15.75 | 89.73 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.22) | (0.69) | (2.21) |
EV/FCF |
(1.19) | (0.67) | (2.15) |
Quick Ratio |
2.27 | 4.27 | 0.59 |
Current Ratio |
2.56 | 4.51 | 0.73 |
Net Debt/EBITDA |
0.43 | 0.92 | 0.14 |
Debt/Assets |
3.07% | 0.00% | 0.17% |
Debt/Equity |
0.05 | 0.00 | (0.15) |
Asset Turnover |
0.00 | 0.05 | 0.04 |
Operating CF/Net income |
0.75 | 0.80 | 0.83 |
Capex/Depreciation |
(2.05) | (1.51) | (1.18) |
Interest Coverage |
(709.04) | (1,667.49) | (1,286.22) |
| 0.00% | (187.03%) | (301.60%) | |
| 0.00% | (137.18%) | (181.58%) | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(244.80%) | (121.36%) | 21,592.66% |
Average Days of Receivables |
54.45 | 28.09 | 6.11 |
Research and Development Expense of Revenue |
1,129.43% | 1,903.48% | 3,613.17% |
Selling, General and Administrative Expense of Revenue |
634.77% | 1,042.80% | 1,365.29% |
Intangible Assets out of Total Assets |
0.01 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.11 | 0.50 | (0.04) |
Graham Number |
0.00 | 0.00 | 0.63 |
Earnings Yield |
(67.22%) | (67.22%) | (51.30%) |
Free Cash Flow Yield |
(69.21%) | (56.20%) | (43.30%) |
Revenue per Share |
0.18 | 0.13 | 0.05 |
Operating CF per Share |
(2.22) | (3.02) | (2.11) |
Capex per Share |
(0.15) | (0.11) | (0.05) |
Free Cash Flow per Share |
(2.37) | (3.14) | (2.16) |
Cash per Share |
1.35 | 3.48 | 0.34 |
Shareholders Equity per Share |
1.21 | 3.10 | (0.01) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
1.21 | 3.10 | (0.01) |
Free Cash Flow |
(37.00) | (63.52) | (79.76) |
Working Capital |
14.77 | 58.09 | (5.70) |
Capital Expenditures |
(2.37) | (2.28) | (1.95) |
Net Current Asset Value |
12.59 | 56.63 | (7.57) |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.87 | 0.84 | 1.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 |
| Other line items | |||
Depreciation/Fixed assets |
0.29 | 0.32 | 0.32 |
Cash ROIC |
(90.41%) | (47.71%) | (645.23%) |
Accounts Receivable Turnover |
0.00 | 8.78 | 15.94 |
Accounts Payable Turnover |
0.00 | 0.32 | 0.07 |
Inventory Turnover |
0.00 | 3.01 | 1.71 |
Average Days of Payables |
616.65 | 1,495.81 | 7,116.54 |
Days of Inventory on Hand |
86.83 | 130.30 | 97.50 |
Average Receivables |
— | 0.31 | 0.12 |
Average Payables |
— | 4.51 | 8.49 |
Average Inventory |
— | 0.48 | 0.33 |
Average Assets |
— | 55.61 | 51.85 |
Average Common Equity |
— | 40.79 | 31.21 |
Columns are period end dates